Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer [Phase 2]
Phase 2 trial of MORAb-003 (farletuzumab) in platinum-resistant or refractory relapsed ovarian cancer was terminated, with results posted in…
-
CLINICAL_TRIALS research · 2017-03-30Clinical Trial Update: A Modified Approach for Morbid Obese With Gynecologic Cancer [NA]
This clinical trial update reports on a study titled 'A Modified Approach for Morbid Obese With Gynecologic Cancer' (NCT03096652) sponsored …
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 study by MedImmune evaluating safety and antitumor activity in adults with advanced solid tumors, including advanced recurrent ovari…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses [NA]
The clinical trial evaluating a simple ultrasound-based rule diagnostic tool for adnexal masses has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients [NA]
The University of Michigan completed a clinical trial evaluating guided imagery as a perioperative intervention in gynecologic oncology pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-03-17FDA Approved: CISPLATIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for cisplatin, a generic injectable chemotherapy agent (ANDA approval).
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission [Phase 1]
A Phase 1 study of a unimolecular pentavalent immunization (Globo-H-GM2-sTn-TF-Tn) in patients with epithelial ovarian cancer, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer [Phase 1]
Phase 1 trial evaluating [18F]Fluciclatide-PET in combination with Pazopanib and Paclitaxel for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse Caregivers [NA]
A completed clinical trial evaluating the Taking Care of Her caregiver support program for patients with Stage III/IV ovarian cancer and the…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer [Phase 2]
Phase 2 efficacy trial of recombinant interleukin-21 for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: OSCA - Olaparib Standard of CAre Study
The OSCA trial evaluating olaparib as standard of care in platinum-sensitive recurrent serous ovarian cancer has completed.
-
CLINICAL_TRIALS research · 2017-02-28Clinical Trial Update: Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma [Phase 2]
A Phase 2 study is evaluating paclitaxel, carboplatin, and oral metformin for advanced epithelial ovarian cancer; the trial status is curren…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer [Phase 2]
Phase 2 trial update on allogeneic natural killer (NK) cells for ovarian, fallopian tube, peritoneal, and metastatic breast cancer; study co…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer [Phase 3]
This is a Phase 3 clinical trial evaluating whether intravenous glutathione can prevent paclitaxel/carboplatin-induced peripheral neuropathy…
-
CLINICAL_TRIALS withdrawal · 2017-02-23Clinical Trial Update: TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer [Phase 3]
Amgen's TRINOVA-3 Phase 3 trial evaluating AMG 386 with paclitaxel and carboplatin for ovarian, fallopian tube, and peritoneal cancers has b…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating STM-434 alone or with liposomal doxorubicin in ovarian cancer, fallopian tube cancer, endometrial cancer, and other…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study of topotecan in combination with carboplatin for relapsed ovarian cancer, …
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: BRCA1 and BRCA2 Mutation in Romanian Population: a Study of Genotype - Phenotype Correlation at Diagnosis With Prospective Disease Outcome and Survival
A completed study assessing the prevalence and penetrance of BRCA1 and BRCA2 mutations in Romanian women with breast or ovarian cancer, and …
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: High-dose ICE With Amifostine [Phase 2]
Phase 2 trial evaluating high-dose ICE chemotherapy with Amifostine has completed accrual and results are reported for multiple solid tumors…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer [Phase 2]
The update reports completion of a Phase 2 trial evaluating the safety and effects of EMD 72000 in subjects with recurrent ovarian cancer.
-
FDA approval · 2017-01-19FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
The FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of lenalidomide with doxorubicin liposome in recurrent ovarian, fallopian tube, or primary peritoneal cancer; the s…
-
CLINICAL_TRIALS research · 2017-01-16Clinical Trial Update: The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
This document discusses analyses of treatment efficacy and cost-effectiveness in patients with early-stage ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer [Phase 1]
A Phase 1 study of DMOT4039A in participants with unresectable pancreatic cancer or platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Internet-based System for Cancer Patients to Self-report Toxicity [NA]
This updates on a completed clinical trial evaluating an internet-based system that allows cancer patients to self-report treatment-related …